Product details

Share this page:
Please find below the full details of the product you clicked a link to view.
Published by:
Stanford Business School (2012)
Version:
6 March 2012
Length:
4 pages
Data source:
Field research

Abstract

This is part of a case series. In addition to acquiring Millennium Pharmaceuticals in 2008 and Amgen Japan in 2009, Takeda implemented a major reorganization of its global organization. President Yasuchika Hasegawa reorganized Takeda’s business in the US and aggressively expanded its global business. For the first time in Takeda’s history, Hasegawa appointed several non-Japanese to executive positions and moved away from a Japanese-centric governance system. Hasegawa felt confident that Takeda was becoming a global company and moving towards his vision of innovation, cultural transformation, and growth.

Topics

Mergers and Acquisitions (M&A); Growth strategy; Restructuring; Pharmaceuticals; Decision making; Emerging markets; Business processes; Strategic planning

Access this item

casecent.re/p/111422
View our pricing guide
or to see prices.

Reviews & usage